Sequencing Treatments for Mothers With ADHD and Their At - Risk Children
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
We hypothesize that successfully treating maternal Attention Deficit Hyperactivity Disorder
(ADHD) will have a beneficial effect that extends to the child. We believe that
multi-component interventions combining maternal stimulant medication, Lisdexamfetamine
(LDX), and Behavioral Parent Training (BPT) will improve parenting, maternal, and child
outcomes. In terms of improved parenting, we hypothesize that some mothers may respond well
to LDX or BPT alone and therefore may not require multi-modal treatment, whereas others may
benefit most from multi-modal treatment